clinical trial News
-
Clinical trials explained
On November 4, Jeanette Prangsgaard held a presentation at the ‘Clinical Trials’ even, organised by Synapse – Life Science Connect Aalborg. Jeanette spoke about clinical trials, what they entail, and what her role is in the process of the development of our prophylactic HPV vaccine, to pique the interest of students and recent graduates. The aim of the event is to bridge the ...
-
Biobeat is excited to join forces with Medidata Solutions and be part of the Sensor Cloud Network
Biobeat is excited to join forces with Medidata Solutions and be part of the Sensor Cloud Network. By using Biobeat’s medical-grade wearables we are able to enhance clinical trials with vital signs collection to generate real-world evidence remotely and conveniently from the patient’s home. Our platform supports decentralized clinical trials and significantly reduces the logistics ...
-
Clinical Trial Design Trends for 2023
About the webinar 2020/21 led to significant clinical trial innovation in clinical trials in response to the Covid-19 pandemic with 2022 providing key insights, projects and lessons in the wider clinical trials space. 2023 will see these lessons merge with long-term trends and the lessons from important pilot programs to see wider use of innovative designs and methods. In this webinar, we look ...
By Statsol
-
Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, announced that the Food and Drug Administration (FDA) has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed. As previously announced, the Phase III clinical trial was placed on clinical hold by the FDA ...
-
SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox
NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. In recent weeks, randomized, placebo-controlled clinical trials were initiated in ...
-
Novadiscovery appoints Gregoire Boutonnet as Chief Operating Officer
Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and optimize clinical trial development, today announces the appointment of Grégoire Boutonnet as Chief Operating Officer, effective immediately. In his new role, Grégoire will ensure alignment between NOVA’s business strategy, operations and growth objectives, as well ...
-
Showcase
A Phase Ii Trial Of Onapristone In Combination With Fulvestrant For Patients With Er-Positive And Her2-Negative Metastatic Breast Cancer After Progression On Endocrine Therapy And Cdk 4/6 Inhibitors
Antiprogestins act as Progesterone Receptor (PgR) antagonists. Novel and promising class of drugs to overcome endocrine resistance associated with ESR1 mutations. SMILE STUDY is a multi-institutional phase II clinical trial to determine the efficacy of an antiprogestin, Onapristone +fulvestrantas second line therapy for patients with HR+/HER2- metastatic breast cancer (MBC). Hypothesis: The ...
-
Baymatob™ proudly hosts the launch of the Ingham Institute`s centre for Robotics and Health Technology
Today the Ingham Institute launched their centre for Robotics and Health Technology from the BaymatobTM premises. The Institute is one of the only in Australia to combine clinical expertise with commercial partnerships to oversee the life cycle of bringing life-saving treatments to market – from concepts to clinical trials to commercialisation and introduction into the healthcare systems. ...
-
Clinical Trial Managers Need to Know These Skills for the Future
The Covid-19 epidemic has changed the world in many ways, and many clinical trials have been done to research more about it. According to the World Health Organization (WHO), 12,969 clinical trials were done in America in 2021. Even in pre-pandemic times, clinical trials have always been an ongoing process. Clinical trial managers work on cutting-edge studies and contribute to ...
By Brio Group
-
First Home-Use Trial of the Bihormonal iLet With Dasiglucagon in a Pre-Filled, Commercial Ready, Pump Cartridge
This home-use clinical trial is being conducted by Dr. Steven Russell and his clinical research team at the Massachusetts General ...
-
Showcase
Atmo Biosciences awarded Australian Government grant to automate and scale-up manufacturing of ingestible gas-sensing capsule
Atmo Biosciences has been awarded an Australian Government Manufacturing Modernisation Fund (MMF) grant to support manufacturing automation and scale-up for the Atmo Gas-Sensing Capsule. The Round 2 MMF grants, part of the Government’s Modern Manufacturing Strategy, are for small-medium sized businesses to transform manufacturing and to support job growth and develop a more skilled ...
-
Vestech works with Urucu to establish clinical trials
Urucu, a Brazilian natural therapy, has been launched in Australia as a skin moisturizer. Vestech is assisting IPS, the makers of Urucu, with developing a clinical trial strategy to assess the validity of a number of therapeutic claims made for this compound in ...
-
DEFYMED at SFD congress in Nice (France)
Several people of the team (Severine, Karine and Manuel) are really happy to participate to the annual congress of the French society of diabetes (SFD) which will take place in Nice (South of France) from March 22nd to 25th. The team will be in the start-up booth E02 to present our latest news but also a unique chance for you to take in hands our ExOlin® device which is the latest innovation ...
By Defymed
-
Showcase
POP Biotechnologies Vaccine Technology to Enter Phase III Clinical Studies as part of Eubiologics’ COVID-19 Vaccine Candidate, EuCorVac-19
POP Biotechnologies (POP BIO), a Buffalo, NY based biopharmaceutical startup, announces the approval of the plan for a phase 3 clinical study of EuCorVac-19, a COVID-19 vaccine candidate developed by South Korean partner EuBiologics (KOSDAQ: 206650, CEO, Dr. Baik YoungOk, Mr. Seukkeun Choi) from the Ministry of Food and Drug Safety in South Korea. EuCorVac-19, is a protein-based vaccine ...
-
German Federal Ministry of Education and Research („BMBF“) selects tiakis Biotech AG to develop Tiprelestat as a potential therapeutic for COVID-19.
tiakis Biotech AG (formerly Proteo Biotech AG) has announced that the German BMBF has selected the Company to conduct a clinical phase 1b/2 trial to develop its investigational medical product Tiprelestat as a potential therapeutic for COVID-19. The aim of the clinical trial is to assess Tiprelestat’s efficacy to attenuate severe disease progression of COVID-19. The Company expects the ...
-
NeuroScientific Biopharmaceuticals Investor Webinar Presentation – ShareCafe Small Cap “Hidden Gems”
NeuroScientific Biopharmaceuticals Director of Operations, Dr Alexandra Andrews provided an overview of the Company’s peptide-based drug for the treatment of neurodegenerative conditions and an update on the Company's progress towards clinical trials. To see video, please click ...
-
How Great Clinical Trial Managers Stand Out From The Rest
Clinical Trial Manager roles are growing 32% faster than the national average. This job is undeniably rewarding but requires a high level of expertise and a knack for research. A clinical trial manager is responsible for many tasks, including overseeing everything from creating a valid test to its administration, recruitment, logistics, and follow-up. Hence, specific abilities ...
By Brio Group
-
Analysis of Equipoise Shift in CLOTBUST-ER Has Been Published
Therapeutic Advances in Neurological Disorders has published “Endovascular equipoise shift in a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke”. This paper presents a case study of the CLOTBUST-ER trial, showing that the “increasing implementation of endovascular therapies across major academic stroke centers raises significant challenges for ...
-
In the hands of ADAMO Robot
The clinical trials conducted by La Rioja’s healthcare service demonstrates the effectiveness of the only therapeutic massage robotic device that uses pressurized air to treat back pain. ...
By Adamo Robot
-
FRONTBIO Inc IND Approval for Phase 1 Clinical Trial for Eczema Treatment
FRONTBIO, a new drug development bio company, announced on the 5th that it had received approval from the Ministry of Food and Drug Safety on the 2th of last month for a phase 1 clinical trial (IND) for 'FB1A1,' a new drug candidate material under development for the treatment of eczema. FB1A1 treats eczema by normalizing the hypersensitive immune response caused by the imbalance of cytokines ...
By Frontbio
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you